Bologna, Italy

Guiseppe Glaudio Viscomi


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guiseppe Glaudio Viscomi: Innovator in Pharmaceutical Chemistry

Introduction

Guiseppe Glaudio Viscomi is a notable inventor based in Bologna, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of polymorphic forms of rifaximin, an important antibiotic.

Latest Patents

Viscomi holds a patent for the crystalline polymorphous forms of rifaximin, specifically rifaximin α, rifaximin β, and a poorly crystalline form named rifaximin γ. This invention is crucial for the production of medicinal preparations containing rifaximin for both oral and topical use. The patent details a crystallization process involving the hot-dissolving of raw rifaximin in ethyl alcohol, followed by controlled crystallization through the addition of water at specific temperatures and durations. The final product undergoes drying under controlled conditions to achieve a settled water content.

Career Highlights

Viscomi is associated with Alfa Wassermann S.p.a., a company known for its focus on pharmaceutical innovations. His work has contributed to advancements in antibiotic formulations, enhancing their efficacy and usability in medical treatments.

Collaborations

Throughout his career, Viscomi has collaborated with esteemed colleagues such as Manuela Campana and Dario Braga. These partnerships have fostered a collaborative environment that promotes innovation in pharmaceutical research.

Conclusion

Guiseppe Glaudio Viscomi's contributions to the field of pharmaceutical chemistry, particularly through his patent on rifaximin polymorphs, highlight his role as an innovator in the industry. His work continues to impact the development of effective medicinal preparations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…